Assistant Researcher to the unit Diabetic Complications Full-time

Assistant Researcher to the Unit Diabetic Complications

Lund University was founded in 1666 and is repeatedly ranked among the world's top universities. The University has around 46,000 students and 8,500 staff based in Lund, Helsingborg, and Malmö. We are united in our efforts to understand, explain, and improve our world and the human condition.

The position is based at the Department of Clinical Sciences in Malmö, in the Diabetic Complications unit at Lund University Diabetes Centre (LUDC), led by Professor Maria F. Gomez and within the strategic research area EXODIAB (Excellence of Diabetes Research in Sweden). LUDC is one of the largest diabetes research centres in the world with approximately 300 researchers and administrative and technical staff members working towards improved diagnosis, prevention, and treatment of diabetes. A central theme at LUDC is to develop precision medicine to improve health and the quality of life of patients with diabetes.

Within the research group, we foster a good working environment with respect and consideration in our relationships to each other and strive for a workplace that is developing and stimulating for all employees.

Lund University is a public authority, which means that you are entitled to special benefits, generous annual leave, and a favorable occupational pension. We also have a flextime agreement, which contributes to good conditions for a healthy work–life balance.

The focus of this position is on cardiovascular-kidney-metabolic (CKM) syndrome, characterized by overlapping type 2 diabetes (T2D), chronic kidney disease (CKD), and cardiovascular disease (CVD). CKM syndrome is a leading cause of premature mortality and healthcare burden globally. We are now looking for an enthusiastic and talented person to strengthen the Unit's expertise in data mining, artificial intelligence, epidemiology, public health, and systems medicine within the framework of precision medicine. We expect the successful applicant to have experience of programming, data analysis, and data mining to identify trends and produce meaningful data visualizations, as well as experience of working with different bioinformatics tools and statistical methods. The applicant is expected to leverage multi-modal data to identify biologically and clinically meaningful subtypes of CKM syndrome, establish their prognostic significance, and uncover predictive biomarkers for treatment response. The applicant is expected to have excellent communications skills and to want to interact with other researchers.

The following qualifications are required:

• PhD in clinical pharmacy and pharmacology
• Experience as clinical and translational scientist specializing in precision medicine for cardiometabolic diseases, particularly type 2 diabetes and chronic kidney disease.
• Postdoctoral research experience at a leading international institution (e.g. top-tier university or medical research centre).
• Expertise in epidemiology and population research, including design and analysis of cohort and registry studies to define disease risk, progression, and treatment outcomes. Skills in applying causal inference, survival analysis, and longitudinal modelling to link clinical and biological data.
• Expertise in predictive modelling and AI applications, including development and validation of machine-learning and statistical models for disease prediction, prognosis, and therapeutic response. Proficient in R, SAS, and other bioinformatic tools for data integration and advanced analytics.
• Expertise in biomarker discovery and precision medicine, including multi-omics research involving clinical trials/longitudinal cohort datasets to identify biomarkers for therapeutic response and disease progression to advance precision medicine
• Expertise in clinical and translational study design, including interventional and observational studies, integrating mechanistic hypotheses with clinical endpoints.
• Grant writing and research funding: Proven track record of securing competitive funding. Experienced in proposal writing, budget justification, and progress reporting
• Extensive international experience across Asia, Europe, and North America. Skilled in managing partnerships with pharmaceutical companies, regulatory agencies, and global health organizations
• Track record of high-impact publications and conference presentations. Effective in communicating complex findings to scientific, clinical, and policy audiences.
• Experienced in supervising and mentoring junior fellows, promoting a supportive, collaborative learning environment.
• Experience supporting WHO and UN initiatives to strengthen health systems for diabetes and obesity management in low- and middle-income countries. Skilled in institutional context analysis, stakeholder engagement, and the development of sustainable, evidence-based policy frameworks.
• We will also pay attention to personal attributes, favouring individuals that are self-motivated, flexible, and that can work independently in a well-documented way, to manage multiple projects in parallel and to prioritize and comply with deadlines.

The following qualifications are considered an asset:

• Additional clinical proficiency and fellowships.
• Documented research supervision and teaching experience.

This is a full-time (100%) permanent position with a preliminary starting date May 1, 2026, or according to agreement.

Applications are submitted through the University's recruitment system. The application must include a personal letter describing how you meet the qualification requirements and why you are interested in the position. The application must also include a CV, a copy of your doctoral degree certificate, and a list of publications.